Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :827
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Samarium-153 ethylenediamine tetramethylene phosphonate therapy for bone pain palliation in skeletal metastases

Tripathi M, Singhal T, Chandrasekhar N, Kumar P, Bal C, Jhulka P K, Bandopadhyaya G, Malhotra A

Year : 2006| Volume: 43| Issue : 2 | Page no: 86-92

   This article has been cited by
 
1 Leveraging the power of non-radium radionuclide treatments in bone metastases
Pradeep Thapa,Sandip Basu
The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2019; 63(2)
[Pubmed]  [Google Scholar] [DOI]
2 The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone
A. Hussain,R.J. Lee,J.N. Graff,S. Halabi
Critical Reviews in Oncology/Hematology. 2019; 139: 108
[Pubmed]  [Google Scholar] [DOI]
3 Personalized Radiation Therapy in Cancer Pain Management
Ewa Sierko,Dominika Hempel,Konrad Zuzda,Marek Wojtukiewicz
Cancers. 2019; 11(3): 390
[Pubmed]  [Google Scholar] [DOI]
4 Efficacy and safety of 153Sm-EDTMP as treatment of painful bone metastasis: a large single-center study
Hélène Kolesnikov-Gauthier,Nathalie Lemoine,Emmanuelle Tresch-Bruneel,Anaïs Olivier,Aurore Oudoux,Nicolas Penel
Supportive Care in Cancer. 2018; 26(3): 751
[Pubmed]  [Google Scholar] [DOI]
5 Comparative Therapeutic Efficacy of 153Sm-EDTMP and 177Lu-EDTMP for Bone Pain Palliation in Patients with Skeletal Metastases: Patients’ Pain Score Analysis and Personalized Dosimetry
Sarika Sharma,Baljinder Singh,Ashwani Koul,Bhagwant Rai Mittal
Frontiers in Medicine. 2017; 4
[Pubmed]  [Google Scholar] [DOI]
6 Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review
Joyce M. van Dodewaard-de Jong,Daniela E. Oprea-Lager,Lotty Hooft,John M.H. de Klerk,Haiko J. Bloemendal,Henk M.W. Verheul,Otto S. Hoekstra,Alfons J.M. van den Eertwegh
European Urology. 2016; 70(3): 416
[Pubmed]  [Google Scholar] [DOI]
7 Burden of skeletal-related events in prostate cancer: unmet need in pain improvement
M. S. Broder,B. Gutierrez,D. Cherepanov,Y. Linhares
Supportive Care in Cancer. 2014;
[Pubmed]  [Google Scholar] [DOI]
8 Pain Palliative Therapy in Women with Breast Cancer Osseous Metastatic Disease and the Role of Specific Serum Cytokines as Prognostic Factors
Ioannis Iakovou,Argyrios Doumas,Kosmas Badiavas,Vassileios Mpalaris,Savvas Frangos,Georgios Farmakis
Cancer Biotherapy and Radiopharmaceuticals. 2014; 29(3): 116
[Pubmed]  [Google Scholar] [DOI]
9 The cumulative analgesic consumption score (CACS): evaluation of a new score to describe postsurgical analgesic consumption as a surrogate parameter for postoperative pain and invasiveness of surgical procedures
Martin Schoenthaler,Arkadiusz Miernik,Klaus Offner,Wojciech Konrad Karcz,Dieter Hauschke,Sabina Sevcenco,Franklin Emmanuel Kuehhas,Christian Bach,Noor Buchholz,Konrad Wilhelm
International braz j urol. 2014; 40(3): 330
[Pubmed]  [Google Scholar] [DOI]
10 Samarium-153-ethylene diamine tetramethylene phosphonate (EDTMP) therapy in the management of refractory bone pain in a patient with carcinoma prostate and diffuse bone metastasis
R. Narayan,T. Kalawat,R.G. Manthri,A.Y. Lakshmi,B. Vijaylakshmi Devi,N. Anil Kumar
Journal of Clinical & Scientific Research. 2013; 2(4): 239
[Pubmed]  [Google Scholar] [DOI]
11 Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: A phase II study
Yuan, J. and Liu, C. and Liu, X. and Wang, Y. and Kuai, D. and Zhang, G. and Zaknun, J.J.
Clinical Nuclear Medicine. 2013; 38(2): 88-92
[Pubmed]  [Google Scholar]
12 Modeling the time dependent biodistribution of Samarium-153 ethylenediamine tetramethylene phosphonate using compartmental analysis
Parandoush Abbasian,Monika Foroghy,Amir Reza Jalilian,Amir Hakimi,Simindokht Shirvani-Arani
Reports of Practical Oncology & Radiotherapy. 2013;
[Pubmed]  [Google Scholar] [DOI]
13 Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate Cancer
Jie Yuan,Congjin Liu,Xingdang Liu,Yuankai Wang,Dayu Kuai,Guangming Zhang,John J. Zaknun
Clinical Nuclear Medicine. 2013; 38(2): 88
[Pubmed]  [Google Scholar] [DOI]
14 Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: A systematic review and meta-analysis
DæAngelo, G. and Sciuto, R. and Salvatori, M. and Sperduti, I. and Mantini, G. and Maini, C.L. and Marian, G.
Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2012; 56(6): 538-543
[Pubmed]  [Google Scholar]
15 The Vienna protocol and perspectives in radionuclide therapy
Sinzinger, H. and Palumbo, B. and Ozker, K.
Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2011; 55(4): 420-430
[Pubmed]  [Google Scholar]
16 Radiopharmaceuticals: When and How to Use Them to Treat Metastatic Bone Pain
Fabio M. Paes, Vinicius Ernani, Peter Hosein, Aldo N. Serafini
The Journal of Supportive Oncology. 2011; 9(6): 197
[HTML Full text]  [Google Scholar] [DOI]
17 Targeted radiotherapy of bone malignancies
Jansen, D.R. and Krijger, G.C. and Kolar, Z.I. and Zonnenberg, B.A. and Zeevaart, R.
Current Drug Discovery Technologies. 2010; 7(4): 233-246
[Pubmed]  [Google Scholar]
18 Systemic Metabolic Radiopharmaceutical Therapy in the Treatment of Metastatic Bone Pain
Fabio M. Paes,Aldo N. Serafini
Seminars in Nuclear Medicine. 2010; 40(2): 89
[Pubmed]  [Google Scholar] [DOI]
19 Systemic Metabolic Radiopharmaceutical Therapy in the Treatment of Metastatic Bone Pain
Paes, F.M., Serafini, A.N.
Seminars in Nuclear Medicine. 2010; 40(2): 89-104
[Pubmed]  [Google Scholar]
20 Palliation therapy for painful skeletal metastasis with Sm-153
Zisimopoulos, A., Psyllas, D., Babatsikou, F., Kyriatzis, G., Karathanos, E., Koutis, C.
Review of Clinical Pharmacology and Pharmacokinetics, International Edition. 2009; 23(2): 85-88
[Pubmed]  [Google Scholar]
21 Improvement in Sensory Pain Rating After Palliative Systemic Radionuclide Therapy in Patients With Advanced Prostate Cancer
Frank J Papatheofanis,Cynthia Smith,Mohammad Najib
American Journal of Therapeutics. 2009; 16(2): 127
[Pubmed]  [Google Scholar] [DOI]
22 Improvement in sensory pain rating after palliative systemic radionuclide therapy in patients with advanced prostate cancer
Papatheofanis, F.J. and Smith, C. and Najib, M.
American Journal of Therapeutics. 2009; 16(2): 127-132
[Pubmed]  [Google Scholar]
23 153Sm: Its use in multiple myeloma and report of a clinical experience
Abruzzese, E., Iuliano, F., Trawinska, M.M., Di Maio, M.
Expert Opinion on Investigational Drugs. 2008; 17(9): 1379-1387
[Pubmed]  [Google Scholar]
24 153Sm: its use in multiple myeloma and report of a clinical experience
Elisabetta Abruzzese,Francesco Iuliano,Malgorzata Monika Trawinska,Massimo Di Maio
Expert Opinion on Investigational Drugs. 2008; 17(9): 1379
[Pubmed]  [Google Scholar] [DOI]
25 The Prevalence and Motivation of Cigarette Smoking among Kerman high school students
Ziaaddini, H. and Zarezadeh, A.
Iranian J Psychiatry. 2007; 2(1): 41-45
[Pubmed]  [Google Scholar]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow